These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 31446140)
1. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma. Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140 [TBL] [Abstract][Full Text] [Related]
2. Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules. Zhou D; Li YQ; Liu QX; Deng XF; Chen L; Li MY; Zhang J; Lu X; Zheng H; Dai JG Cancer Med; 2024 Jun; 13(11):e7383. PubMed ID: 38864483 [TBL] [Abstract][Full Text] [Related]
3. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers. Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263 [TBL] [Abstract][Full Text] [Related]
4. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma. Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966 [TBL] [Abstract][Full Text] [Related]
5. Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma. Xiang C; Ji C; Cai Y; Teng H; Wang Y; Zhao R; Shang Z; Guo L; Chen S; Lizaso A; Lin J; Wang H; Li B; Zhang Z; Zhao J; Wei J; Liu J; Zhu L; Fang W; Han Y Mod Pathol; 2022 Sep; 35(9):1181-1192. PubMed ID: 35641658 [TBL] [Abstract][Full Text] [Related]
6. Genomic and immune profiling of pre-invasive lung adenocarcinoma. Chen H; Carrot-Zhang J; Zhao Y; Hu H; Freeman SS; Yu S; Ha G; Taylor AM; Berger AC; Westlake L; Zheng Y; Zhang J; Ramachandran A; Zheng Q; Pan Y; Zheng D; Zheng S; Cheng C; Kuang M; Zhou X; Zhang Y; Li H; Ye T; Ma Y; Gao Z; Tao X; Han H; Shang J; Yu Y; Bao D; Huang Y; Li X; Zhang Y; Xiang J; Sun Y; Li Y; Cherniack AD; Campbell JD; Shi L; Meyerson M Nat Commun; 2019 Nov; 10(1):5472. PubMed ID: 31784532 [TBL] [Abstract][Full Text] [Related]
7. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database]. Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272 [TBL] [Abstract][Full Text] [Related]
8. Differences in Immunological Landscape between Luo JW; Guo YH; Wu FY; Li XF; Sun XC; Wang JL; Zhou CC Dis Markers; 2021; 2021():3776854. PubMed ID: 34484468 [TBL] [Abstract][Full Text] [Related]
10. Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma. Lin Y; Li D; Hui H; Miao H; Luo M; Roy B; Chen B; Zhang W; Shao D; Ma D; Jie Y; Qiu F; Li H; Jiang B Front Oncol; 2024; 14():1389618. PubMed ID: 38803537 [TBL] [Abstract][Full Text] [Related]
11. Genomic Underpinnings of Tumor Behavior in Qian J; Zhao S; Zou Y; Rahman SMJ; Senosain MF; Stricker T; Chen H; Powell CA; Borczuk AC; Massion PP Am J Respir Crit Care Med; 2020 Mar; 201(6):697-706. PubMed ID: 31747302 [No Abstract] [Full Text] [Related]
12. Genetic Alterations in Preinvasive Lung Synchronous Lesions. Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981 [TBL] [Abstract][Full Text] [Related]
13. Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma. Zhou J; Lin H; Ni Z; Luo R; Yang D; Feng M; Zhang Y BMC Pulm Med; 2023 Jan; 23(1):18. PubMed ID: 36647116 [TBL] [Abstract][Full Text] [Related]
14. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study. Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486 [TBL] [Abstract][Full Text] [Related]
15. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less Petterson J; Mustafa D; Bandaru S; Eklund EÄ; Hallqvist A; Sayin VI; Gagné A; Fagman H; Akyürek LM Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474205 [TBL] [Abstract][Full Text] [Related]
17. Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors. Yang CY; Liao WY; Ho CC; Chen KY; Tsai TH; Hsu CL; Su KY; Chang YL; Wu CT; Hsu CC; Liao BC; Hsu WH; Lee JH; Lin CC; Shih JY; Yang JC; Yu CJ Eur J Cancer; 2020 Jan; 124():110-122. PubMed ID: 31760310 [TBL] [Abstract][Full Text] [Related]
18. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276 [TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ. Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies. Nakamura H; Koizumi H; Kimura H; Marushima H; Saji H; Takagi M Lung Cancer; 2016 Sep; 99():143-7. PubMed ID: 27565930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]